» Articles » PMID: 27643442

Different Activation Signals Induce Distinct Mast Cell Degranulation Strategies

Abstract

Mast cells (MCs) influence intercellular communication during inflammation by secreting cytoplasmic granules that contain diverse mediators. Here, we have demonstrated that MCs decode different activation stimuli into spatially and temporally distinct patterns of granule secretion. Certain signals, including substance P, the complement anaphylatoxins C3a and C5a, and endothelin 1, induced human MCs rapidly to secrete small and relatively spherical granule structures, a pattern consistent with the secretion of individual granules. Conversely, activating MCs with anti-IgE increased the time partition between signaling and secretion, which was associated with a period of sustained elevation of intracellular calcium and formation of larger and more heterogeneously shaped granule structures that underwent prolonged exteriorization. Pharmacological inhibition of IKK-β during IgE-dependent stimulation strongly reduced the time partition between signaling and secretion, inhibited SNAP23/STX4 complex formation, and switched the degranulation pattern into one that resembled degranulation induced by substance P. IgE-dependent and substance P-dependent activation in vivo also induced different patterns of mouse MC degranulation that were associated with distinct local and systemic pathophysiological responses. These findings show that cytoplasmic granule secretion from MCs that occurs in response to different activating stimuli can exhibit distinct dynamics and features that are associated with distinct patterns of MC-dependent inflammation.

Citing Articles

Mast Cells at the Crossroads of Hypersensitivity Reactions and Neurogenic Inflammation.

Aitella E, Romano C, Ginaldi L, Cozzolino D Int J Mol Sci. 2025; 26(3).

PMID: 39940696 PMC: 11817554. DOI: 10.3390/ijms26030927.


Immune control of brain physiology.

Kovacs M, Dominguez-Belloso A, Ali-Moussa S, Deczkowska A Nat Rev Immunol. 2025; .

PMID: 39890999 DOI: 10.1038/s41577-025-01129-6.


Human intraepithelial mast cell differentiation and effector function are directed by TGF-β signaling.

Derakhshan T, Hollers E, Perniss A, Ryan T, McGill A, Hacker J J Clin Invest. 2025; 135(1).

PMID: 39744949 PMC: 11684804. DOI: 10.1172/JCI174981.


Neuronal substance P-driven MRGPRX2-dependent mast cell degranulation products differentially promote vascular permeability.

Nagamine M, Kaitani A, Izawa K, Ando T, Yoshikawa A, Nakamura M Front Immunol. 2024; 15:1477072.

PMID: 39640264 PMC: 11617324. DOI: 10.3389/fimmu.2024.1477072.


Mast Cells and Mas-related G Protein-coupled Receptor X2: Itching for Novel Pathophysiological Insights to Clinical Relevance.

Castells M, Madden M, Oskeritzian C Curr Allergy Asthma Rep. 2024; 25(1):5.

PMID: 39585499 PMC: 11588779. DOI: 10.1007/s11882-024-01183-5.


References
1.
Subramanian H, Kashem S, Collington S, Qu H, Lambris J, Ali H . PMX-53 as a dual CD88 antagonist and an agonist for Mas-related gene 2 (MrgX2) in human mast cells. Mol Pharmacol. 2011; 79(6):1005-13. PMC: 3102546. DOI: 10.1124/mol.111.071472. View

2.
Gaudenzio N, Laurent C, Valitutti S, Espinosa E . Human mast cells drive memory CD4+ T cells toward an inflammatory IL-22+ phenotype. J Allergy Clin Immunol. 2013; 131(5):1400-7.e11. DOI: 10.1016/j.jaci.2013.01.029. View

3.
Burke J, Pattoli M, Gregor K, Brassil P, MacMaster J, McIntyre K . BMS-345541 is a highly selective inhibitor of I kappa B kinase that binds at an allosteric site of the enzyme and blocks NF-kappa B-dependent transcription in mice. J Biol Chem. 2002; 278(3):1450-6. DOI: 10.1074/jbc.M209677200. View

4.
Dudeck A, Dudeck J, Scholten J, Petzold A, Surianarayanan S, Kohler A . Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens. Immunity. 2011; 34(6):973-84. DOI: 10.1016/j.immuni.2011.03.028. View

5.
Bochner B, Charlesworth E, Lichtenstein L, Derse C, Gillis S, Dinarello C . Interleukin-1 is released at sites of human cutaneous allergic reactions. J Allergy Clin Immunol. 1990; 86(6 Pt 1):830-9. DOI: 10.1016/s0091-6749(05)80143-5. View